Title How did the two years of the COVID-19 pandemic affect the outcomes of the patients with inflammatory rheumatic diseases in Lithuania? /
Authors Dadonienė, Jolanta ; Jasionytė, Gabija ; Mironova, Julija ; Staškuvienė, Karolina ; Miltinienė, Dalia
DOI 10.3390/medicina59020311
Full Text Download
Is Part of Medicina (Lithuania).. Basel : MDPI. 2023, vol. 59, iss. 2, art. no. 311, p. [1-10].. ISSN 1010-660X. eISSN 1648-9144
Keywords [eng] COVID-19 ; excess mortality ; rheumatic diseases ; standardized mortality ratio
Abstract [eng] Background and objectives: the COVID-19 pandemic globally caused more than 18 million deaths over the period of 2020–2021. Although inflammatory rheumatic diseases (RD) are generally associated with premature mortality, it is not yet clear whether RD patients are at a greater risk for COVID-19-related mortality. The aim of our study was to evaluate mortality and causes of death in a retrospective inflammatory RD patient cohort during the COVID-19 pandemic years. Methods: We identified patients with a first-time diagnosis of inflammatory RD and followed them up during the pandemic years of 2020–2021. Death rates, and sex- and age-standardized mortality ratios (SMRs) were calculated for the prepandemic and pandemic periods. Results: We obtained data from 11,636 patients that had been newly diagnosed with inflammatory RD and followed up until the end of 2021 or their death. The mean duration of the follow-up was 5.5 years. In total, 1531 deaths occurred between 2013 and 2021. The prevailing causes of death in the prepandemic period were cardiovascular diseases, neoplasms, and diseases of the respiratory system. In the pandemic years, cardiovascular diseases and neoplasms remained the two most common causes of death, with COVID-19 in third place. The SMR of the total RD cohort was 0.83. This trend was observed in rheumatoid arthritis and spondyloarthropathy patients. The SMR in the group of connective-tissue diseases and vasculitis was higher at 0.93, but did not differ from that of the general population. The excess of deaths in the RD cohort during the pandemic period was negative (−27.2%), meaning that RD patients endured the pandemic period better than the general population did. Conclusions: The COVID-19 pandemic did not influence the mortality of RD patients. Strict lockdown measures, social distancing, and early vaccination were the main factors that resulted in reduced mortality in this cohort during the pandemic years.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2023
CC license CC license description